Divi's Labs, TVS Motor seen replacing Nifty names in March 2027 review
In short
Divi's Laboratories and TVS Motor Company are seen as likely to enter the Nifty index at the March 2027 review. They could replace Max Healthcare Institute and HDFC Life, and the estimate mentioned is about $824 million in inflows.
The review is still in an early stage, so the final list may change. Investors are watching because index changes can move share demand.
What the reporting says
Divi's Laboratories and TVS Motor Company are being flagged as likely replacements for Max Healthcare Institute and HDFC Life in the NSE Nifty review in March 2027. The publisher-supplied summary says Quiddity Leaderboard estimates about $824 million of inflows if the changes happen, and it also points to possible further Nifty 100 rank shifts. The review is still early, so the final index changes remain unknown.
Why it matters
Divi's Laboratories and TVS Motor Company are being cited as likely candidates for inclusion in the Nifty at the March 2027 review, potentially replacing Max Healthcare Institute and HDFC Life. The summary says Quiddity Leaderboard estimates around $824 million in inflows if the change happens. Because the review is still nascent, the final composition and any broader Nifty 100 reshuffle remain unknown.